Browse Category

Dividends News 26 September 2025 - 21 October 2025

HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

Stock Performance & Dividend Announcement HTCR’s stock surged on Oct. 20, 2025, when the company revealed the $0.13/share dividend Globenewswire. In after-hours trading, the share price jumped roughly 40% Investing. (According to Investing.com, HeartCore stock “surged 40% in after-hours trading on Monday” after the dividend news Investing.) By Oct. 21, HTCR traded around $0.71 Reuters. The stock’s 52-week range is…
PetroChina Stock Jumps on Oil Boom, Dividend Windfall & Stablecoin Ambitions

PetroChina Stock Jumps on Oil Boom, Dividend Windfall & Stablecoin Ambitions

Stock Price on the Rise PetroChina’s Hong Kong-listed H-shares have been on a notable upswing in recent months. On October 20, the stock jumped to HK$7.65, gaining +4.5% in a single session Reuters Reuters. Investors bid up the price amid a broader oil sector rally and optimism around the company’s latest moves. At current levels, PetroChina is trading near its…
Texas Instruments (TXN) Stock Price Today Soars Amid Dividend Hike & AI Boom: Rally Ahead or More Pain? 🎯

Texas Instruments (TXN) Stock Price Today Soars Amid Dividend Hike & AI Boom: Rally Ahead or More Pain? 🎯

What to Know Before Markets Open on October 20, 2025 Bottom Line:Texas Instruments stock is at a crossroads in late 2025. It offers a healthy dividend, fortress financials, and industry leadership in analog chips – qualities that have long attracted value investors. Yet the stock’s recent underperformance reflects real concerns: growth has stalled post-pandemic, and the market’s hype has shifted…
Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Earnings Beat Sparks Relief Rally Truist’s third-quarter results breezed past expectations, providing a jolt of good news for the regional banking sector. Net income available to common shareholders came in at $1.35 billion (EPS $1.04), exceeding analysts’ $0.99 forecast Investing and slightly above $0.99 in the prior-year quarter. Revenue of $5.24 billion (taxable-equivalent) was roughly in line with estimates Investing, as strong…
U.S. Bancorp Stock Soars on Earnings Beat, Dividend Hike, and New Crypto Push

U.S. Bancorp Stock Soars on Earnings Beat, Dividend Hike, and New Crypto Push

USB Stock Price & Recent Trends U.S. Bancorp’s stock (USB) is trading around $47 per share following the earnings news, up from roughly $46 before the report. The upbeat Q3 results sparked a ~3% jump in pre-market and early session trading Chartmill, as investors reacted to the better-than-expected profit numbers. This marks a sharp reversal of the stock’s recent trajectory…
BCE Stock’s Wild Ride: Dividend Drama, Bold Turnaround Plan & Analyst Predictions

BCE Stock’s Wild Ride: Dividend Drama, Bold Turnaround Plan & Analyst Predictions

Stock Price Check: Recent Movements As of October 14, 2025, BCE Inc.’s stock is trading around the mid-C$33 range after a period of extreme volatility. It closed at C$33.41 on the Toronto Stock Exchange, notching a slight decline on the day Stockchase. This price marks a modest recovery from the C$28.73 low reached earlier in the year, but shares remain…
CNQ Stock Skyrocketing? Oil Rally, 25-Year Dividends & Expert Forecasts (Oct 2025)

CNQ Stock Skyrocketing? Oil Rally, 25-Year Dividends & Expert Forecasts (Oct 2025)

CNQ Stock Price & Recent Performance CNQ’s stock has climbed in recent weeks. The TSX-listed share reached ~C$45.55 on Oct 9 Simplywall (about $31.40 on NYSE). This is near its 3-year high (∼C$48), though still below the 2023 peak (~C$52). Over the last week it gained ~3% Simplywall, driven by a bounce in oil prices and positive sentiment. For context, CNQ…
3M Stock Set to Soar! PFAS Settlement and Dividends Spark Rally (Oct 2025)

3M Stock Set to Soar! PFAS Settlement and Dividends Spark Rally (Oct 2025)

Stock Price & Recent Performance 3M’s stock has been trading in the low-to-mid $150s this autumn. As of Oct 10, 2025, it closed near $148.75 Tradingview. That day’s drop (~–2.7%) came amid broad market pullback. Over the past week MMM has slid roughly –6.4% Tradingview, reversing part of its earlier gains. (Year-to-date MMM was up ~10.6% Tradingview, roughly in line with the S&P 500.)…
Tesco Shares Soar After Double‑Digit Dividend Hike: What Investors Need to Know

Tesco Shares Soar After Double‑Digit Dividend Hike: What Investors Need to Know

Tesco’s Winning Strategy: Value, Loyalty and Efficiency Tesco’s half‑year results highlight how the UK’s largest grocer continues to grow despite intense competition from German discounters Aldi and Lidl. Group sales climbed 5.1% to £33 billion while adjusted operating profit edged up 1.5% Directorstalkinterviews. Chief executive Ken Murphy said the business grew sales in each of its divisions and achieved market‑share gains by…
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Stock Price and Recent Performance Pfizer’s stock has struggled in 2025, hovering near multi-year lows. At ~$23.60 per share in late September, PFE has declined about 9% since January, underperforming the S&P 500 (which is up modestly) and lagging the broader healthcare sector. Over the past 12 months, the stock is down roughly 18%. The 52-week high was $30.43, and…
1 48 49 50

Stock Market Today

  • Electrosurgical Devices Market to Reach $9.25 Billion by 2033 on Aging Population and Tech Advances
    January 30, 2026, 7:49 AM EST. The global electrosurgical devices market is forecasted to grow from USD 6.92 billion in 2024 to USD 9.25 billion by 2033 at a 3.2% CAGR. Growth drivers include rising surgical volumes caused by aging populations and chronic diseases. Increasing adoption of minimally invasive surgeries, continuous technological improvements like advanced energy devices and safety features, and expanding healthcare expenditure in emerging markets also fuel demand. Enhanced clinical efficacy and safety help reduce intraoperative blood loss and procedure times. Investments in advanced devices rise as hospitals seek better outcomes for the growing elderly patient base, especially in regions with aging demographics such as Japan, Europe, and North America. The market outlook reflects rising needs due to chronic disease prevalence and increasing surgeries globally.
Go toTop